V. Carson

598 total citations
21 papers, 483 citations indexed

About

V. Carson is a scholar working on Cardiology and Cardiovascular Medicine, Animal Science and Zoology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, V. Carson has authored 21 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 4 papers in Animal Science and Zoology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in V. Carson's work include Cardiac electrophysiology and arrhythmias (4 papers), Cardiac Imaging and Diagnostics (3 papers) and Cardiovascular Function and Risk Factors (3 papers). V. Carson is often cited by papers focused on Cardiac electrophysiology and arrhythmias (4 papers), Cardiac Imaging and Diagnostics (3 papers) and Cardiovascular Function and Risk Factors (3 papers). V. Carson collaborates with scholars based in Australia, Sri Lanka and United States. V. Carson's co-authors include Iain B. McInnes, T. E. Lowe, Winifred G. Nayler, W. G. Nayler, Alex Bobik, D. Race, WG Nayler, Helen Skews, Geoffrey A. Head and Paul Körner and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Cardiovascular Research and European Journal of Pharmacology.

In The Last Decade

V. Carson

21 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Carson Australia 13 285 115 76 70 63 21 483
Herman B. Daniell United States 9 143 0.5× 88 0.8× 50 0.7× 40 0.6× 75 1.2× 15 414
C Labrid France 12 180 0.6× 204 1.8× 88 1.2× 49 0.7× 56 0.9× 35 510
M. N. Hussain Canada 9 185 0.6× 88 0.8× 83 1.1× 81 1.2× 63 1.0× 14 450
E Moerman Belgium 14 241 0.8× 166 1.4× 114 1.5× 126 1.8× 52 0.8× 45 625
C Valori Italy 7 332 1.2× 113 1.0× 43 0.6× 69 1.0× 76 1.2× 20 606
M Taeschler Japan 9 171 0.6× 93 0.8× 69 0.9× 61 0.9× 25 0.4× 41 485
E. F. Woods United States 14 305 1.1× 108 0.9× 58 0.8× 57 0.8× 98 1.6× 37 634
A A McLeod United Kingdom 14 349 1.2× 83 0.7× 38 0.5× 41 0.6× 100 1.6× 24 624
Ronald R. Tuttle United States 11 439 1.5× 181 1.6× 117 1.5× 84 1.2× 176 2.8× 26 863
J. S. Stephenson United Kingdom 6 140 0.5× 132 1.1× 57 0.8× 52 0.7× 45 0.7× 8 463

Countries citing papers authored by V. Carson

Since Specialization
Citations

This map shows the geographic impact of V. Carson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Carson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Carson more than expected).

Fields of papers citing papers by V. Carson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Carson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Carson. The network helps show where V. Carson may publish in the future.

Co-authorship network of co-authors of V. Carson

This figure shows the co-authorship network connecting the top 25 collaborators of V. Carson. A scholar is included among the top collaborators of V. Carson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Carson. V. Carson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bobik, Alex, Julie H. Campbell, V. Carson, & Gordon Campbell. (1981). Mechanism of Isoprenaline-Induced Refractoriness of the β-Adrenoceptor—Adenylate Cyclase Syste in Chick Embryo Cardiac Cells. Journal of Cardiovascular Pharmacology. 3(3). 541–553. 33 indexed citations
2.
Carson, V., et al.. (1980). Simple and sensitive procedure for the assay of serotonin and catecholamines in brain by high-performance liquid chromatography using fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 182(3). 277–284. 43 indexed citations
3.
Körner, Paul, J.A. Reynoldson, Geoffrey A. Head, J. R. Oliver, & V. Carson. (1979). Effect of 6-Hydroxydopamine on Baroreceptor-Heart Rate and Nasopharyngeal Reflexes of the Rabbit. Journal of Cardiovascular Pharmacology. 1(3). 311–328. 27 indexed citations
4.
Körner, Paul, et al.. (1978). Cardiovascular and behavioral effects of intracisternal 6-hydroxydopamine in the rabbit. European Journal of Pharmacology. 53(1). 83–93. 29 indexed citations
5.
Barnett, A. J., et al.. (1977). PLASMA LEVELS FOLLOWING SINGLE INTRAVENOUS, ORAL AND MULTIPLE ORAL DOSAGE IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS. Clinical and Experimental Pharmacology and Physiology. 4(4). 331–339. 11 indexed citations
6.
Nayler, W. G. & V. Carson. (1973). Effect of stellate ganglion stimulation on myocardial blood flow, oxygen consumption, and cardiac efficiency during beta-adrenoceptor blockade. Cardiovascular Research. 7(1). 22–29. 33 indexed citations
7.
Carson, V., et al.. (1972). Effect of phentolamine on myocardial function and noradrenaline levels in coronary blood plasma. Cardiovascular Research. 6(5). 500–507. 3 indexed citations
8.
Nayler, W. G., et al.. (1971). Effect of dopamine on coronary vascular resistance and myocardial function. Cardiovascular Research. 5(2). 161–168. 19 indexed citations
9.
Carson, V., et al.. (1971). Pharmacological effects of H 56/28: a new  -antagonist on the cardiovascular system. Cardiovascular Research. 5(3). 383–395. 1 indexed citations
10.
Nayler, Winifred G., et al.. (1970). THE EFFECT OF GLUCAGON ON CALCIUM EXCHANGEABILITY, CORONARY BLOOD FLOW, MYOCARDIAL FUNCTION AND HIGH ENERGY PHOSPHATE STORES. Journal of Pharmacology and Experimental Therapeutics. 171(2). 265–275. 20 indexed citations
11.
Nayler, Winifred G., et al.. (1969). THE EFFECT OF BETA ADRENERGIC ANTAGONISTS ON CARDIAC CONTRACTIONS, MYOFIBRILLAR ATPASE ACTIVITY, HIGH-ENERGY PHOSPHATE STORES AND LIPID-FACILITATED TRANSPORT OF CALCIUM IONS. Journal of Pharmacology and Experimental Therapeutics. 165(2). 225–233. 5 indexed citations
12.
Nayler, Winifred G., et al.. (1969). The effect of beta adrenergic antagonists on cardiac contractions, myofibrillar ATPase activity, high-energy phosphate stores and lipid-facilitated transfort of calciumiones.. PubMed. 165(2). 225–33. 32 indexed citations
13.
Nayler, Winifred G., et al.. (1969). The effect of lignocaine on myocardial function, high energy phosphate stores, and oxygen consumption: A comparison with propranolol. American Heart Journal. 78(3). 338–345. 17 indexed citations
14.
Nayler, Winifred G., et al.. (1969). The combined effect of atropine and β-adrenergic receptor antagonists on left ventricular function and coronary blood flow. American Heart Journal. 77(2). 246–258. 9 indexed citations
15.
Nayler, WG, et al.. (1968). SOME EFFECTS OF IPROVERATRIL (ISOPTIN) ON THE CARDIOVASCULAR SYSTEM. Journal of Pharmacology and Experimental Therapeutics. 161(2). 247–261. 81 indexed citations
16.
Nayler, Winifred G., et al.. (1968). Some effects of diphenylhydantoin and propranolol on the cardiovascular system. American Heart Journal. 75(1). 83–96. 25 indexed citations
17.
Nayler, W. G., et al.. (1968). Some effects of the hypotensive drug diazoxide on the cardiovascular system. American Heart Journal. 75(2). 223–232. 24 indexed citations
18.
Nayler, Winifred G., et al.. (1967). Effect of propranolol, a beta-adrenergic antagonist, on blood flow in the coronary and other vascular fields. American Heart Journal. 73(2). 207–216. 65 indexed citations
19.
Barnett, A. J., et al.. (1964). “ATROMID” IN ATHEROSCLEROSIS. The Medical Journal of Australia. 2(1). 19–24. 1 indexed citations
20.
Barnett, A. J. & V. Carson. (1963). REDUCTION OF PLASMA CHOLESTEROL LEVELS IN ATHERO‐SCLEROSIS BY DIET AND DRUG TREATMENT. Australasian Annals of Medicine. 12(1). 37–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Herman B. Daniell Breakdown of academic impact, for papers by C Labrid Breakdown of academic impact, for papers by M. N. Hussain Breakdown of academic impact, for papers by E Moerman Breakdown of academic impact, for papers by C Valori Breakdown of academic impact, for papers by M Taeschler Breakdown of academic impact, for papers by E. F. Woods Breakdown of academic impact, for papers by A A McLeod Breakdown of academic impact, for papers by Ronald R. Tuttle Breakdown of academic impact, for papers by J. S. Stephenson
Rankless by CCL
2026